Decisions about dendritic cells: Past, present, and future

Annual Review of Immunology

Volumn 30, Issue , 2012, Pages 1-22

  Steinman, Ralph M ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Adaptive immunity; Adjuvants; Antigen presentation; Immunotherapy

Indexed keywords

B7 ANTIGEN; CD11B ANTIGEN; CD14 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; FLT3 LIGAND; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MICRORNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY NLDC 145; MUTANT PROTEIN; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRINITROPHENYL; TUMOR ANTIGEN; UNCLASSIFIED DRUG; VACCINE; ZINC FINGER PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTIVE IMMUNITY; ASTHMA; ATHEROSCLEROSIS; AUTOIMMUNITY; BONE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CELL TYPE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DRUG DESIGN; DRUG SCREENING; ENDOCYTOSIS; ENTERITIS; FOLLICULAR DENDRITIC CELL; GRAM NEGATIVE BACTERIUM; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IN VIVO STUDY; INNATE IMMUNITY; JUVENILE DIABETES MELLITUS; LEUKAPHERESIS; LYMPHOCYTE TRANSFORMATION; MACROPHAGE; MAST CELL; MULTIPLE SCLEROSIS; NATURAL KILLER T CELL; NEOPLASM; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TRANSPORT; RECEPTOR BINDING; REVIEW; RNA VIRUS; T LYMPHOCYTE; THROMBOCYTE; THYMOCYTE; TRANSPLANTATION; VACCINATION;

ALLERGY AND IMMUNOLOGY; ANIMALS; ANTIGENS, CD; BONE MARROW CELLS; CELL DIFFERENTIATION; DENDRITIC CELLS; HEMATOPOIETIC STEM CELLS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; LECTINS, C-TYPE; MODELS, ANIMAL; RECEPTORS, CELL SURFACE; VACCINES;

EID: 84857793524     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-100311-102839     Document Type: Review

References (134)

1. Steinman RM. 2004. Dendritic cells: from the fabric of immunology. Clin. Investig. Med. 27:231-36
2. Steinman RM. 2007. Dendritic cells: understanding immunogenicity. Eur. J. Immunol. 37:S53-60
3. Burnet FM. 1957. A modification of Jerne's theory of antibody production using the concept of clonal selection. Aust. J. Sci. 20:67-69
4. FishmanM, Adler FL. 1963. Antibody formation initiated in vitro. II. Antibody synthesis in x-irradiated recipients of diffusion chambers containing nucleic acid derived from macrophages incubated with antigen. J. Exp. Med. 117:595-602
5. Askonas BA, Rhodes JM. 1965. Immunogenicity of antigen-containing ribonucleic acid preparations from macrophages. Nature 205:470-74
6. Gottlieb AA, Glisin VR, Doty P. 1967. Studies on macrophage RNA involved in antibody production. Proc. Natl. Acad. Sci. USA 57:1849-56
7. Brent L, Medawar PB. 1967. Cellular immunity and the homograft reaction. Br. Med. Bull. 23:55-60
8. Gowans JL. 1965. The role of lymphocytes in the destruction of homografts. Br. Med. Bull. 21:106-10
9. Mishell RI, Dutton RW. 1967. Immunization of dissociated spleen cell cultures from normal mice. J. Exp. Med. 126:423-42
10. Steinman RM, Cohn ZA. 1973. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137:1142-62
11. Steinman RM, Cohn ZA. 1974. Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. J. Exp. Med. 139:380-97
12. de Duve C, Pressman BC, Gianetto R, Wattiaux R, Appelmans F. 1955. Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat liver tissue. Biochem. J. 60:604-17
13. Steinman RM, Moberg CL. 1995. A tribute to Zanvil Alexander Cohn. The macrophage in cell biology and resistance to infectious disease. J. Exp. Med. 179:1-30
14. Steinman RM, Kaplan G, Witmer MD, Cohn ZA. 1979. Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, andmaintenance in vitro. J. Exp. Med. 149:1-16
15. Nossal GJV, Abbot A, Mitchell J, Lummus Z. 1968. Antigen in immunity. XV. Ultrastructural features of antigen capture in primary and secondary lymphoid follicles. J. Exp. Med. 127:277-96
16. Chen LL, Adams JC, Steinman RM. 1978. Anatomy of germinal centers in mouse spleen with special reference to "follicular dendritic cells. " J. Cell Biol. 77:148-64
17. Chen LL, Frank AM, Adams JC, Steinman RM. 1978. Distribution of horseradish peroxidase [HRP]-anti HRP immune complexes in mouse spleen, with special reference to follicular dendritic cells. J. Cell Biol. 79:184-99
18. Steinman RM, Cohn ZA. 1972. The interaction of soluble horseradish peroxidase withmouse peritoneal macrophages in vitro. J. Cell Biol. 55:186-204
19. Steinman RM, Cohn ZA. 1975. A novel adherent cell in mouse lymphoid organs. In Immune Recognition, ed. AS Rosenthal, pp. 571-87. San Francisco: CA: Academic
20. Steinman RM, WitmerMD. 1978. Lymphoid dendritic cells are potent stimulators of the primarymixed leukocyte reaction in mice. Proc. Natl. Acad. Sci. USA 75:5132-36
21. Lechler RI, Batchelor JR. 1982. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J. Exp. Med. 155:31-41
22. Klinkert WEF, Labadie JH, Bowers WE. 1982. Accessory and stimulating properties of dendritic cells and macrophages isolated from various rat tissues. J. Exp. Med. 156:1-19
23. Austyn JM, Steinman RM, Weinstein DE, Granelli-Piperno A, Palladino MA. 1983. Dendritic cells initiate a two-stage mechanism for T lymphocyte proliferation. J. Exp. Med. 157:1101-15
24. Nussenzweig MC, Steinman RM, Gutchinov B, Cohn ZA. 1980. Dendritic cells are accessory cells for the development of anti-trinitrophenyl cytotoxic T lymphocytes. J. Exp. Med. 152:1070-84
25. Van Voorhis WC, Valinsky J, Hoffman E, Luban J, Hair LS, Steinman RM. 1983. Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication. J. Exp. Med. 158:174-91
26. Inaba K, Nakano K, Muramatsu S. 1981. Cellular synergy in the manifestation of accessory cell activity for in vitro antibody response. J. Immunol. 127:453-61
27. Inaba K, Steinman RM, Van VoorhisWC, Muramatsu S. 1983. Dendritic cells are critical accessory cells for thymus-dependent antibody responses in mouse and man. Proc. Natl. Acad. Sci. USA 80:6041-45
28. Steinman RM, Nussenzweig MC. 1980. Dendritic cells: features and functions. Immunol. Rev. 53:127-47
29. Tew JG, Thorbecke J, Steinman RM. 1982. Dendritic cells in the immune response: characteristics and recommended nomenclature. J. Reticuloendothel. Soc. 31:371-80
30. InabaK, SteinmanRM. 1984. Resting and sensitizedTlymphocytes exhibit distinct stimulatory (antigenpresenting cell) requirements for growth and lymphokine release. J. Exp. Med. 160:1717-35
31. Inaba K, Steinman RM. 1985. Protein-specific helper T lymphocyte formation initiated by dendritic cells. Science 229:475-79
32. + cytotoxic T lymphocytes by dendritic cells. J. Exp. Med. 166:182-94
33. Koide SL, Inaba K, Steinman RM. 1987. Interleukin-1 enhances T-dependent immune responses by amplifying the function of dendritic cells. J. Exp. Med. 165:515-30
34. Steinman RM, Inaba K. 1989. Immunogenicity: role of dendritic cells. BioEssays 10:145-52
35. Steinman RM. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271-96
36. Witmer MD, Steinman RM. 1984. The anatomy of peripheral lymphoid organs with emphasis on accessory cells: light microscopic, immunocytochemical studies of mouse spleen, lymph node and Peyer's patch. Am. J. Anat. 170:465-81
37. Schuler G, Steinman RM. 1985. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161:526-46
38. Witmer-Pack MD, Olivier W, Valinsky J, Schuler G, Steinman RM. 1987. Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J. Exp. Med. 166:1484-98
39. Pierre P, Turley SJ, Gatti E, Hull M, Meltzer J, et al. 1997. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388:787-92
40. Trombetta ES, Ebersold M, Garrett W, Pypaert M, Mellman I. 2003. Activation of lysosomal function during dendritic cell maturation. Science 299:1400-3
41. Inaba K, Turley S, Iyoda T, Yamaide F, Shimoyama S, et al. 2000. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J. Exp. Med. 191:927-36
42. Turley SJ, Inaba K, Garrett WS, Ebersold M, Untermaehrer J, et al. 2000. Transport of peptide-MHC class II complexes in developing dendritic cells. Science 288:522-27
43. Romani N, Koide S, Crowley M, Witmer-Pack M, Livingstone AM, et al. 1989. Presentation of exogenous protein antigens by dendritic cells to T cell clones: intact protein is presented best by immature, epidermal Langerhans cells. J. Exp. Med. 169:1169-78
44. Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM. 2003. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a co-administered protein. J. Exp. Med. 198:267-79
45. Fujii S, Liu K, Smith C, Bonito AJ, Steinman RM. 2004. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199:1607-18
46. Hammad H, Lambrecht BN. 2011. Dendritic cells and airway epithelial cells at the interface between innate and adaptive immune responses. Allergy 66:579-87
47. Ronnblom L, Pascual V. 2008. The innate immune system in SLE: type I interferons and dendritic cells. Lupus 17:394-99
48. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, et al. 1992. Generation of large numbers of dendritic cells from mouse bonemarrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693-702
49. Inaba K, Steinman RM, Witmer-Pack M, Aya H, Inaba M, et al. 1992. Identification of proliferating dendritic cell precursors in mouse blood. J. Exp. Med. 175:1157-67
50. Inaba K, Inaba M, Deguchi M, Hagi K, Yasumizu R, et al. 1993. Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow. Proc. Natl. Acad. Sci. USA 90:3038-42
51. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. 1992. GM-CSF and TNF-αcooperate in the generation of dendritic Langerhans cells. Nature 360:258-61
52. Inaba K, Inaba M, Naito M, Steinman RM. 1993. Dendritic cell progenitors phagocytose particulates, including Bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J. Exp. Med. 178:479-88
53. Sallusto F, Lanzavecchia A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 971:81-9011
54. Romani N, Gruner S, Brang D, K̈ampgen E, Lenz A, et al. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83-93
55. Sallusto F, Cella M, Danieli C, Lanzavecchia A. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:389-400
56. Inaba K, Metlay JP, Crowley MT, Steinman RM. 1990. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172:631-40
57. Dhodapkar MV, Steinman RM, Sapp M, Desai H, Fossella C, et al. 1999. Rapid generation of broad T-cell immunity in humans after single injection of mature dendritic cells. J. Clin. Investig. 104:173-80
58. + T-cell in humans without foreign helper epitopes. J. Clin. Investig. 105:R9-14
59. Vremec D, Lieschke GJ, Dunn AR, Robb L, Metcalf D, Shortman K. 1997. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur. J. Immunol. 27:40-44
60. Maraskovsky E, Brasel K, TeepeM, Roux ER, Lyman SD, et al. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953-62
61. Maraskovsky E, Daro E, Roux E, Teepe M, Maliszewski CR, et al. 2000. In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 96:878-84
62. D'Amico A, Wu L. 2003. The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3. J. Exp. Med. 198:293-303
63. + dendritic cells in vivo. J. Exp. Med. 198:305-13
64. Waskow C, Liu K, Darrasse-J̀eze G, Guermonprez P, Ginhoux F, et al. 2008. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat. Immunol. 9:676-83
65. Liu K, Victora GD, Schwickert TA, Guermonprez P, Meredith MM, et al. 2009. In vivo analysis of dendritic cell development and homeostasis. Science 324:392-97
66. Liu K, Waskow C, Liu X, Yao K, Hoh J, Nussenzweig M. 2007. Origin of dendritic cells in peripheral lymphoid organs of mice. Nat. Immunol. 8:578-83
67. Merad M, Ginhoux F, Collin M. 2008. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat. Rev. Immunol. 8:935-47
68. Anandasabapathy N, Victora GD, Meredith M, Feder R, Dong B, et al. 2011. Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain. J. Exp. Med. 208:1695-705
69. + dendritic cells for immune T cell areas. Cell 143:416-29
70. Choi J-H, Cheong C, Dandamudi DB, Park CG, Rodriguez AM, et al. 2011. Flt3 signaling dependent dendritic cells protect atherosclerosis via regulatory T cell homeostasis. Immunity. In press
71. Regnault A, Lankar D, Lacabanne V, RodriguezA, Thery C, et al. 1999. Fcγreceptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 189:371-80
72. Albert ML, Sauter B, Bhardwaj N. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86-89
73. Cisse B, Caton ML, Lehner M, Maeda T, Scheu S, et al. 2008. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135:37-48
74. Nussenzweig MC, Steinman RM, Unkeless JC, Witmer MD, Gutchinov B, Cohn ZA. 1981. Studies of the cell surface of mouse dendritic cells and other leukocytes. J. Exp. Med. 154:168-87
75. Crowley MT, Inaba K, Witmer-Pack MD, Gezelter S, Steinman RM. 1990. Use of the fluorescence activated cell sorter to enrich dendritic cells from mouse spleen. J. Immunol. Methods 133:55-66
76. Metlay JP, Witmer-Pack MD, Agger R, Crowley MT, Lawless D, Steinman RM. 1990. The distinct leukocyte integrins ofmouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J. Exp. Med. 171:1753-71
77. Geissmann F, Gordon S, Hume DA, Mowat AM, Randolph GJ. 2010. Unravelling mononuclear phagocyte heterogeneity. Nat. Rev. Immunol. 10:453-60
78. Kraal G, Breel M, JanseM, Bruin G. 1986. Langerhans cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. J. Exp. Med. 163:981-97
79. Witmer-Pack MD, Swiggard WJ, Mirza A, Inaba K, Steinman RM. 1995. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. II. Expression in situ in lymphoid and nonlymphoid tissues. Cell. Immunol. 163:157-62
80. Swiggard WJ, Mirza A, Nussenzweig MC, Steinman RM. 1995. DEC-205, a 205 kDa protein abundant on mouse dendritic cells and thymic epithelium that is detected by the monoclonal antibody NLDC-145: purification, characterization and N-terminal amino acid sequence. Cell. Immunol. 165:302-11
81. JiangW, Swiggard WJ, Heufler C, Peng M, Mirza A, et al. 1995. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375:151-55
82. Linehan SA, Martinez-Pomares L, Stahl PD, Gordon S. 1999. Mannose receptor and its putative ligands in normal murine lymphoid and nonlymphoid organs: in situ expression of mannose receptor by selected macrophages, endothelial cells, perivascular microglia, andmesangial cells, but not dendritic cells. J. Exp. Med. 189:1961-72
83. MahnkeK, Guo M, Lee S, SepulvedaH, Swain SL, et al. 2000. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class IIpositive lysosomal compartments. J. Cell Biol. 151:673-83
84. Guo M, Gong S, Maric S, Misulovin Z, Pack M, et al. 2000. A monoclonal antibody to the DEC-205 endocytosis receptor on human dendritic cells. Hum. Immunol. 61:729-38
85. Granelli-Piperno A, Pritsker A, Pack M, Shimeliovich I, Arrighi J-F, et al. 2005. Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction. J. Immunol. 175:4265-73
86. Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, et al. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:769-80
87. + T cell tolerance. J. Exp. Med. 196:1627-38
88. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199:1467-77
89. + regulatory T cells. Proc. Natl. Acad. Sci. USA 104:2821-26
90. Liu K, Iyoda T, Saternus M, Kimura Y, Inaba K, Steinman RM. 2002. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196:1091-97
91. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von BoehmerH. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6:1219-27
92. + regulatory T cells by targeting of antigens to immature dendritic cells. Blood 101:4862-69
93. + regulatory T cells. J. Immunol. 181:6923-33
94. Vremec D, ZorbasM, Scollay R, Saunders DJ, Ardavin CF, et al. 1992. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J. Exp. Med. 176:47-58
95. Grouard G, Rissoan M-C, Filgueira L, Durand I, Banchereau J, Liu Y-J. 1997. The enigmatic plasmacytoid T cells develop into dendritic cells with IL-3 and CD40-ligand. J. Exp. Med. 185:1101-11
96. Dzionek A, Fuchs A, Schmidt P, Cremer S, ZyskM, et al. 2000. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 165:6037-46
97. Nussenzweig MC, Steinman RM, Witmer MD, Gutchinov B. 1982. A monoclonal antibody specific for mouse dendritic cells. Proc. Natl. Acad. Sci. USA 79:161-65
98. Dudziak D, Kamphorst AO, Heidkamp GF, Buchholz V, Trumpfheller C, et al. 2007. Differential antigen processing by dendritic cell subsets in vivo. Science 315:107-11
99. Idoyaga J, Cheong C, Suda K, Suda N, Kim JY, et al. 2008. Langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo. J. Immunol. 180:3647-50
100. + killer T cells. J. Exp. Med. 193:405-12
101. Berard F, Blanco P, Davoust J, Neidhart-Berard E-M, Nouri-Shirazi M, et al. 2000. Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J. Exp. Med. 192:1535-44
102. Huang FP, Platt N, Wykes M, Major JR, Powell TJ, et al. 2000. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191:435-43
103. Liu YJ. 2005. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23:275-306
104. HeathWR, Carbone FR. 2009. Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat. Immunol. 10:1237-44
105. Bar-On L, Jung S. 2010. Defining dendritic cells by conditional and constitutive cell ablation. Immunol. Rev. 234:76-89
106. Steinman RM, Banchereau J. 2007. Taking dendritic cells into medicine. Nature 449:419-26
107. + T cells. Science 257:383-87
108. Pope M, Betjes MGH, Romani N, Hirmand H, Cameron PU, et al. 1994. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 78:389-98
109. Sela U, Olds P, Park A, Schlesinger SJ, Steinman RM. 2011. Dendritic cells induce antigen-specific regulatory T cells that prevent graft versus host disease and persist in mice. J. Exp. Med. 208:2489-96
110. Thurner B, Haendle I, R̈oder C, Dieckmann D, Keikavoussi P, et al. 1999. Vaccination withMage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 190:1669-78
111. + progenitor-derived dendritic cell vaccine. Cancer Res. 61:6451-58
112. Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, et al. 1996. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 2:52-58
113. Nestle FO, Banchereau J, Hart D. 2001. Dendritic cells: on the move from bench to bedside. Nat. Med. 7:761-65
114. Figdor CG, De Vries IJ, Lesterhuis WJ, Melief CJ. 2004. Dendritic cell immunotherapy: mapping the way. Nat. Med. 10:475-80
115. Small EJ, Fratesi P, Reese DM, Strang G, Laus R, et al. 2000. Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells. J. Clin. Oncol. 18:3894-903
116. Melief CJ. 2008. Cancer immunotherapy by dendritic cells. Immunity 29:372-83
117. Tacken PJ, de Vries IJM, Torensma R, Figdor CG. 2007. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat. Rev. Immunol. 7:790-802
118. Zitvogel L, Kepp O, Kroemer G. 2011. Immune parameters affecting the efficacy of chemotherapeutic regimens. Nat. Rev. Clin. Oncol. 8:151-60
119. CrowleyM, Inaba K, Steinman RM. 1990. Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins. J. Exp. Med. 172:383-86
120. Bonifaz LC, Bonnyay DP, Charalambous A, Darguste DI, Fujii S, et al. 2004. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199:815-24
121. + T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine. J. Exp. Med. 203:607-17
122. + T cell immunity together with a dendritic cell targeted vaccine. Proc. Natl. Acad. Sci. USA 105:2574-79
123. + T cells in a spectrum of humanMHC I haplotypes. Proc. Natl. Acad. Sci. USA 104:1289-94
124. Wang B, Kuroiwa JM, He LZ, Charalambous A, Keler T, Steinman RM. 2009. The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells. Ann. NY Acad. Sci. 1174:6-17
125. Akira S, Takeda K, Kaisho T. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675-80
126. Stahl-Hennig C, Eisenblatter M, Jasny E, Rzehak T, Tenner-Racz K, et al. 2009. Synthetic doublestranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques. PLoS Pathog. 5:e1000373
127. + Th1 immunity with poly IC as adjuvant. J. Exp. Med. 206:1589-602
128. Caskey M, Lefebvre F, Filali-Mouhim A, Cameron MJ, Goulet J-P, et al. 2011. Synthetic doublestranded RNA induces innate immune responses similar to a live viral vaccine in humans. J. Exp. Med. 208:2357-66
129. Pantel A, Cheong C, Dandamudi DB, Shrestha E, Mehandru S, Steinman RM. 2011. A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T cell immunity in vivo. Eur. J. Immunol. doi: 10. 1002/eji. 20114185
130. Vulink A, Radford KJ, Melief C, Hart DN. 2008. Dendritic cells in cancer immunotherapy. Adv. Cancer Res. 99:363-407
131. Idoyaga J, Lubkin A, Fiorese C, Lahoud MH, Caminschi I, et al. 2011. ComparableThelper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proc. Natl. Acad. Sci. USA 108:2384-89
132. Flynn BJ, Kastenmüller K, Wille-Reece U, Tomaras GD, Alam SM, et al. 2011. Immunization with HIV Gag targeted to dendritic cells followed by recombinant NYVAC induces robust T cell immunity in nonhuman primates. Proc. Natl. Acad. Sci. USA 108:7131-36
133. Cheong C, Choi JH, Vitale L, He LZ, Trumpfheller C, et al. 2010. Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody. Blood 116:3828-38
134. Hemmi H, Idoyaga J, Suda K, Suda N, Kennedy K, et al. 2009. A new triggering receptor expressed on myeloid cells (Trem) family member, Trem-like 4, binds to dead cells and is a DNAX activation protein 12-linked marker for subsets of mouse macrophages and dendritic cells. J. Immunol. 182:1278-86